A Brief Cognitive Task Intervention for NHS Staff Affected by COVID-19 Trauma (GAINS-2 Study)
NCT ID: NCT05616676
Last Updated: 2024-03-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
122 participants
INTERVENTIONAL
2022-12-08
2024-03-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The study is funded by the Wellcome Trust (223016/Z/21/Z).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Brief GAmeplay Intervention for NHS ICU Staff Affected by COVID-19 Trauma (GAINS Study)
NCT04992390
Computer Assisted Lessening of Intrusive Memories in the Emergency Department
NCT04769999
Treatment of Post Traumatic Stress Disorder in Patients With Other Mental Illnesses
NCT00053690
A Deployment Focused Pragmatic Trial of Optimal Stepped Care Intervention Targeting PTSD and Comorbidity for Acutely Hospitalized Injury Survivors Treated in US Trauma Care Systems
NCT05632770
Cognitive Training for PTSD
NCT03316196
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Regular monitoring will be performed by P1vital Products to verify that the study is conducted, and data are generated, documented and reported in compliance with the protocol, GCP and the applicable regulatory requirements. Quality assurance representatives from the Sponsor may carry out an audit of the study in compliance with regulatory guidelines and relevant standard operating procedures.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Brief digital imagery-competing task
Access to a brief digital imagery-competing task for 24 weeks (first 4 weeks with optional researcher support).
Brief digital imagery-competing task
First session guided by a researcher: A memory cue followed by playing a computer game with mental rotation instructions.
Option to engage in self-administered/guided sessions after the first session.
Brief digital music-listening task
Access to a brief digital music-listening task for 24 weeks (first 4 weeks with optional researcher support).
Brief digital music-listening task
First session guided by a researcher: Information about the composer's music followed by listening to classical music.
Option to engage in self-administered/guided sessions after the first session.
Treatment As Usual
Access to routine care that participants would otherwise receive if having intrusive memories of traumatic events for 24 weeks.
Treatment As Usual
Access to routine care that participants would otherwise receive if having intrusive memories of traumatic events.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Brief digital imagery-competing task
First session guided by a researcher: A memory cue followed by playing a computer game with mental rotation instructions.
Option to engage in self-administered/guided sessions after the first session.
Brief digital music-listening task
First session guided by a researcher: Information about the composer's music followed by listening to classical music.
Option to engage in self-administered/guided sessions after the first session.
Treatment As Usual
Access to routine care that participants would otherwise receive if having intrusive memories of traumatic events.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to read, write and speak in English.
* Worked in a clinical role with COVID-19 patients in the NHS during the COVID-19 pandemic.
* Experienced at least one traumatic event related to their clinical work during the COVID- 9 pandemic meeting criterion A of the Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5) criteria for Post-Traumatic Stress Disorder (PTSD): "exposure to actual or threatened death, serious injury, or sexual violence" by "directly experiencing the traumatic event(s)" or "witnessing, in person, the event(s) as it occurred to others".
* Experience intrusive memories of the traumatic event(s).
* Experienced at least three intrusive memories in the week prior to screening.
* Have internet access.
* Willing and able to provide informed consent and complete study procedures
* Willing and able to be contacted by the research team during the study period.
* Have not taken part in a previous study of this intervention from this research team
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Wellcome Trust
OTHER
Uppsala University (Department of Psychology)
UNKNOWN
Intensive Care Society (Communication Department)
UNKNOWN
University of Nottingham (Institute of Mental Health)
UNKNOWN
P1vital Products Limited
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Emily Holmes
Role: PRINCIPAL_INVESTIGATOR
Uppsala University (UU), Sweden
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
P1vital Products Ltd
Wallingford, Oxfordshire, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P1V-GAINS-IN02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.